Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1995;86:897-899
© 1995 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, C.
Right arrow Articles by Chan, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, C.
Right arrow Articles by Chan, D.

Articles

Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension

CD Hsu, JA Copel, SF Hong, and DW Chan

OBJECTIVE: To measure the circulating levels of thrombomodulin in women with preeclampsia, gestational hypertension, and chronic hypertension. METHODS: Serum levels of thrombomodulin were measured in 34 women with preeclampsia, 15 with gestational hypertension, 11 with chronic hypertension, and 34 normotensive pregnant women in the third trimester. Preeclampsia, gestational hypertension, and chronic hypertension were defined by ACOG criteria. Soluble thrombomodulin antigen was measured by a two-site enzyme-linked immunosorbent assay. RESULTS: Mean (+/- standard error) serum thrombomodulin levels were significantly higher in patients with preeclampsia (69.7 +/- 6.3 ng/mL) than in those with gestational hypertension (46.0 +/- 3.2 ng/mL) or chronic hypertension (46.2 +/- 3.3 ng/mL), and normotensive controls (50.1 +/- 3.1 ng/mL). There were no significant differences among the gestational hypertension, chronic hypertension, and normotensive control groups. CONCLUSION: Thrombomodulin may serve as a clinically meaningful marker to differentiate preeclampsia from other forms of hypertensive disorders in pregnancy.


This article has been cited by other articles:


Home page
 CLIN APPL THROMB HEMOSTHome page
V. Wiwanitkit
Correlation Between Thrombomodulin and Severe Preeclampsia: A Summary
Clinical and Applied Thrombosis/Hemostasis, January 1, 2008; 14(1): 99 - 101.
[Abstract] [PDF]

Home page
 Reproductive SciencesHome page
R. B. Donker, S. A. Asgeirsdottir, F. Gerbens, M. G. van Pampus, C. G. M. Kallenberg, G. J. t. Meerman, J. G. Aarnoudse, and G. Molema
Plasma Factors in Severe Early-Onset Preeclampsia Do Not Substantially Alter Endothelial Gene Expression In Vitro
Reproductive Sciences, February 1, 2005; 12(2): 98 - 106.
[Abstract] [PDF]

Home page
 LupusHome page
M-C. Boffa and M. Karmochkine
Review : Thrombomodulin: an overview and potential implications in vascular disorders
Lupus, January 1, 1998; 7(2_suppl): S120 - S125.
[Abstract] [PDF]

Home page
 Reproductive SciencesHome page
C.-D. Hsu, J. A. Copel, and D. W. Chan
Antepartum and Postpartum Thrombomodulin Levels in Preeclamptic and Normotensive Pregnancies
Reproductive Sciences, May 1, 1997; 4(3): 135 - 137.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American College of Obstetricians and Gynecologists.